Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of the Renin-Angiotensin-Aldosterone System

• Publication date

  2004-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3317/jraas.2004.004PMID 15136971
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post‐myocardial infarction in rats

  2003cited by this paper
• Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

  2000cited by this paper
• Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients

  2000cited by this paper
• Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo.

  1998cited by this paper
• Early captopril treatment inhibits DNA synthesis in endothelial cells and normalization of maximal coronary flow in infarcted rat hearts.

  1998cited by this paper
• Salt induces vascular AT1 receptor overexpression in vitro and in vivo.

  1998cited by this paper
• Myocardial angiotensin receptors in human hearts

  1998cited by this paper
• Dissociation of blood pressure reduction from end‐organ damage in TGR(mREN2)27 transgenic hypertensive rats

  1998cited by this paper
• Angiotensin-converting enzyme inhibition and salt in experimental myocardial infarction.

  1998cited by this paper
• Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.

  1997cited by this paper
• Dietary salt intake modulates angiotensin II type 1 receptor gene expression.

  1997cited by this paper
• Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.

  1997cited by this paper
• Is medical treatment for angina the most cost-effective option?

  1997cited by this paper
• Sensitivity to ischemia of chronically infarcted rat hearts; effects of long-term captopril treatment.

  1996cited by this paper
• Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart.

  1996cited by this paper
• A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

  1995cited by this paper
• Induction of cardiac angiotensin I-converting enzyme with dietary NaCl-loading in genetically hypertensive and normotensive rats

  1995cited by this paper
• Influence of chronic captopril therapy on the mechanical performance of the infarcted rat heart.

  1994cited by this paper
• Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat.

  1994cited by this paper
• Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition.

  1994cited by this paper
• Selective and time related activation of the cardiac renin-angiotensin system after experimental heart failure: relation to ventricular function and morphology.

  1993cited by this paper
• Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape.

  1992cited by this paper
• Sodium depletion enhances the antiproteinuric effect of ACE inhibition in established experimental nephrosis.

  1992cited by this paper
• Effects of the Angiotensin Converting Enzyme Inhibitor Enalapril on the Long‐term: Progression of Left Ventricular Dysfunction in Patients With Heart Failure

  1992cited by this paper
• Ventricular enlargement following infarction is a modifiable process.

  1991cited by this paper
• Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.

  1991cited by this paper
• Delayed but not immediate captopril therapy improves cardiac function in conscious rats, following myocardial infarction.

  1991cited by this paper
• Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

  1991cited by this paper
• Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

  1989cited by this paper
• Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

  1988cited by this paper
• Modulation of left ventricular hypertrophy by dietary salt and inhibition of angiotensin converting enzyme

  1988cited by this paper
• Cardiac Hypertrophy and Salt Status in Chronic Myocardial Infarction in the Rat: Effects of Enalapril Versus Salt Restriction

  1988cited by this paper
• Diuretic Effects of Angiotensin‐Converting Enzyme Inhibition: Comparison of Low and Liberal Sodium Diet in Hypertensive Patients

  1987cited by this paper
• Myocardial Infarct Size and Ventricular Function in Rats

  1979cited by this paper
• Concentrations of angiotensin-converting enzyme in tissues of the rat.

  1971cited by this paper
• Nephrology Dialysis Transplantation the Blunting of the Antiproteinuric Efficacy of Ace Inhibition by High Sodium Intake Can Be Restored by Hydrochlorothiazide Patients and Methods

  year unknowncited by this paper

• Fixed-dose combination of zofenopril plus hydrochlorothiazide vs. irbesartan plus hydrochlorothiazide in hypertensive patients with established metabolic syndrome uncontrolled by previous monotherapy. The ZAMES study (Zofenopril in Advanced MEtabolic Syndrome)

  2016cites this paper
• Effects of high and low salt intake on left ventricular remodeling after myocardial infarction in normotensive rats.

  2015cites this paper
• Safety and efficacy of the sulfydryl ACE-inhibitor zofenopril in the management of cardiovascular disease

  2011cites this paper
• Safety and Efficacy of the bi-Sulfydryl ACE-Inhibitor Zofenopril in the Management of Cardiovascular Disease

  2009cites this paper
• Sodium status and the response to blockade of the renin-angiotensin system

  2008cites this paper
• Nonpharmacologic Management of Heart Failure

  2008cites this paper
• Towards an integrated approach on RAAS-blockade

  2007cites this paper
• ANGIOTENSIN CONVERTING ENZYME GENOTYPE IN WISTAR RATS

  2007cites this paper
• Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data

  2006cites this paper
• Use of the ACE inhibitor zofenopril in the treatment of ischemic heart disease

  2006cites this paper
• Tissue ACE inhibition and sodium status in left ventricular dysfunction

  2005cites this paper
• University of Groningen Tissue ACE inhibition and sodium status in left ventricular dysfunction

  2005cites this paper
• Beneficial effects of add‐on hydrochlorothiazide in rats with myocardial infarction optimally treated with quinapril

  2005cites this paper
• Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.

  2005cites this paper